Atlas Trials

Subconjunctival Bevacizumab Effect on Bleb Vascularity

Clinical trial NCT00854529 · UNKNOWN

Trial details

NCT number
NCT00854529
Sponsor
Rabin Medical Center
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Bleb VascularityBleb FibrosisTrabeculectomy Failure
Start date
2009-04-01
Primary completion
2011-04-01
Enrollment
60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.